# Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults

> **NCT02153541** · PHASE2 · UNKNOWN · sponsor: **Global United Pharmaceutical Corporation** · enrollment: 50 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Antipyrine-benzocaine otic solution
- **OTHER:** Glycerin with Oxyquinoline Sulfate

## Key facts

- **NCT ID:** NCT02153541
- **Lead sponsor:** Global United Pharmaceutical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-01
- **Primary completion:** 2023-08-01
- **Final completion:** 2023-08-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02153541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02153541, "Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02153541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*